| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |